FDA Inspection 1333018 — Kentucky Blood Center Inc

Kentucky Blood Center Inc — FEI 1048401

The FDA completed an inspection of Kentucky Blood Center Inc on Aug 25, 2026 in Somerset, KY. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Aug 25, 2026
Fiscal Year
2026
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Somerset, KY (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.